Finally, we demonstrate that, in MDA-MB-231, a Bcl-xL-dependent breast cancer cell model, endogenous Bcl-xL can exploit this mechanism to suppress IP3R activity and to counteract Ca2+-driven apoptosis. Here, ITPR1 is linked to breast cancer.